van Houte Hans

CIK 00018172171 companySAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001817217

Recent Transactions

50 trades

Sale
Nurix Therapeutics, Inc.$NRIX
Common Stock
2025-11-03$12.56/sh−6,284→ 37,592 total
Exercise/Conversion
Nurix Therapeutics, Inc.$NRIX
Restricted Stock Units
2025-10-30−3,750→ 22,500 total
Exercise/Conversion
Nurix Therapeutics, Inc.$NRIX
Common Stock
2025-10-30+2,000→ 40,398 total
Exercise/Conversion
Nurix Therapeutics, Inc.$NRIX
Common Stock
2025-10-30+3,750→ 44,148 total
Exercise/Conversion
Nurix Therapeutics, Inc.$NRIX
Restricted Stock Units
2025-10-30−2,000→ 4,000 total
Exercise/Conversion
Nurix Therapeutics, Inc.$NRIX
Restricted Stock Units
2025-10-30−2,886→ 2,887 total
Exercise/Conversion
Nurix Therapeutics, Inc.$NRIX
Common Stock
2025-10-30+2,858→ 47,006 total
Exercise/Conversion
Nurix Therapeutics, Inc.$NRIX
Restricted Stock Units
2025-10-30−2,858→ 28,584 total
Sale
Nurix Therapeutics, Inc.$NRIX
Common Stock
2025-10-30$12.80/sh−3,130→ 43,876 total
Exercise/Conversion
Nurix Therapeutics, Inc.$NRIX
Common Stock
2025-10-30+2,886→ 38,398 total
Sale
Nurix Therapeutics, Inc.$NRIX
Common Stock
2025-08-01$11.03/sh−5,402→ 35,512 total
Exercise/Conversion
Nurix Therapeutics, Inc.$NRIX
Common Stock
2025-07-30+2,886→ 36,610 total
Exercise/Conversion
Nurix Therapeutics, Inc.$NRIX
Common Stock
2025-07-30+2,000→ 38,610 total
Exercise/Conversion
Nurix Therapeutics, Inc.$NRIX
Restricted Stock Units
2025-07-30−2,858→ 31,442 total
Exercise/Conversion
Nurix Therapeutics, Inc.$NRIX
Common Stock
2025-07-30+2,858→ 45,218 total
Sale
Nurix Therapeutics, Inc.$NRIX
Common Stock
2025-07-30$12.01/sh−4,304→ 40,914 total
Exercise/Conversion
Nurix Therapeutics, Inc.$NRIX
Restricted Stock Units
2025-07-30−3,750→ 26,250 total
Exercise/Conversion
Nurix Therapeutics, Inc.$NRIX
Restricted Stock Units
2025-07-30−2,000→ 6,000 total
Exercise/Conversion
Nurix Therapeutics, Inc.$NRIX
Restricted Stock Units
2025-07-30−2,886→ 5,773 total
Exercise/Conversion
Nurix Therapeutics, Inc.$NRIX
Common Stock
2025-07-30+3,750→ 42,360 total
Sale
Nurix Therapeutics, Inc.$NRIX
Common Stock
2025-05-02$11.33/sh−6,198→ 33,724 total
Exercise/Conversion
Nurix Therapeutics, Inc.$NRIX
Restricted Stock Units
2025-04-30−2,000→ 8,000 total
Exercise/Conversion
Nurix Therapeutics, Inc.$NRIX
Restricted Stock Units
2025-04-30−3,750→ 30,000 total
Exercise/Conversion
Nurix Therapeutics, Inc.$NRIX
Common Stock
2025-04-30+3,750→ 42,360 total
Sale
Nurix Therapeutics, Inc.$NRIX
Common Stock
2025-04-30$11.50/sh−2,438→ 39,922 total
Exercise/Conversion
Nurix Therapeutics, Inc.$NRIX
Common Stock
2025-04-30+2,886→ 36,610 total
Exercise/Conversion
Nurix Therapeutics, Inc.$NRIX
Restricted Stock Units
2025-04-30−2,886→ 8,659 total
Exercise/Conversion
Nurix Therapeutics, Inc.$NRIX
Common Stock
2025-04-30+2,000→ 38,610 total
Sale
Nurix Therapeutics, Inc.$NRIX
Common Stock
2025-03-03$14.40/sh−5,125→ 34,424 total
Sale
Nurix Therapeutics, Inc.$NRIX
Common Stock
2025-03-03$15.13/sh−700→ 33,724 total
Award
Nurix Therapeutics, Inc.$NRIX
Employee Stock Option (right to buy)
2025-02-11+75,000→ 75,000 total
Award
Nurix Therapeutics, Inc.$NRIX
Restricted Stock Units
2025-02-11+34,300→ 34,300 total
Exercise/Conversion
Nurix Therapeutics, Inc.$NRIX
Common Stock
2025-01-30+3,750→ 42,360 total
Exercise/Conversion
Nurix Therapeutics, Inc.$NRIX
Common Stock
2025-01-30+2,886→ 36,610 total
Sale
Nurix Therapeutics, Inc.$NRIX
Common Stock
2025-01-30$19.81/sh−2,557→ 39,803 total
Exercise/Conversion
Nurix Therapeutics, Inc.$NRIX
Restricted Stock Units
2025-01-30−3,750→ 33,750 total
Exercise/Conversion
Nurix Therapeutics, Inc.$NRIX
Restricted Stock Units
2025-01-30−2,000→ 10,000 total
Exercise/Conversion
Nurix Therapeutics, Inc.$NRIX
Common Stock
2025-01-30+2,000→ 38,610 total
Sale
Nurix Therapeutics, Inc.$NRIX
Common Stock
2025-01-30$20.33/sh−254→ 39,549 total
Exercise/Conversion
Nurix Therapeutics, Inc.$NRIX
Restricted Stock Units
2025-01-30−2,886→ 11,545 total
Sale
Nurix Therapeutics, Inc.$NRIX
Common Stock
2024-11-01$24.28/sh−3,546→ 33,724 total
Exercise/Conversion
Nurix Therapeutics, Inc.$NRIX
Restricted Stock Units
2024-10-30−3,750→ 37,500 total
Exercise/Conversion
Nurix Therapeutics, Inc.$NRIX
Common Stock
2024-10-30+3,750→ 39,638 total
Exercise/Conversion
Nurix Therapeutics, Inc.$NRIX
Restricted Stock Units
2024-10-30−2,000→ 12,000 total
Exercise/Conversion
Nurix Therapeutics, Inc.$NRIX
Restricted Stock Units
2024-10-30−2,886→ 14,431 total
Exercise/Conversion
Nurix Therapeutics, Inc.$NRIX
Common Stock
2024-10-30+2,000→ 35,888 total
Exercise/Conversion
Nurix Therapeutics, Inc.$NRIX
Common Stock
2024-10-30+2,886→ 33,888 total
Sale
Nurix Therapeutics, Inc.$NRIX
Common Stock
2024-10-30$24.30/sh−2,368→ 37,270 total
Sale
Nurix Therapeutics, Inc.$NRIX
Common Stock
2024-08-26$25.22/sh−20,000→ 31,002 total
Sale
Nurix Therapeutics, Inc.$NRIX
Common Stock
2024-08-01$22.22/sh−100→ 51,002 total

Companies

Nurix Therapeutics, Inc.
Chief Financial Officer
$NRIX

Recent Filings

Address

C/O NURIX THERAPEUTICS, INC. 1700 OWENS STREET, SUITE 205

SAN FRANCISCO, CA, 94158

View on SEC.gov